Denmark · Delayed Price · Currency is DKK ChemoMetec Company Description
ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, and beer.
Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202, a consistent cell counter; NucleoCounter NC-200, an automated cell counter that provides solution for cell counting and cell viability determination; NucleoCounter SP-100, an automated sperm cell counter for use in animal reproduction; and XcytoMatic 40, a cell density and viability analyzer.
In addition, the company provides consumables comprising cassettes, reagents, lysis, and slides; accessories, which include cables, power supplies, software, and labware products, as well as service and validation plans and training.
Further, it develops XcytoMatic 30 cell counter and Xcyto 5, a versatile cell analyzer. ChemoMetec A/S was incorporated in 1997 and is headquartered in Allerod, Denmark.
| Country | Denmark |
| Founded | 1997 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 170 |
| CEO | Martin Behrens |
Contact Details
Address: Gydevang 43 Allerod, 3450 Denmark | |
| Phone | 45 48 13 10 20 |
| Website | chemometec.com |
Stock Details
| Ticker Symbol | CHEMM |
| Exchange | Copenhagen Stock Exchange |
| Fiscal Year | July - June |
| Reporting Currency | DKK |
| ISIN Number | DK0060055861 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Martin Helbo Behrens | Chief Executive Officer |
| Kim Nicolajsen | Chief Financial Officer |
| Bo Melholt Nielsen | Chief Technology and Automation Officer |
| Christopher Runchel M.Sc., Ph.D. | Chief Sales Officer |
| Søren Kjærulff | Head of Research & Development |
| Emil Sondergaard | Chief Commercial Officer |